Chronic Hepatitis B
Chronic Hepatitis B Study-I
A clinical study on Hepatitis B was started from April 2004 to December 2004. It was an Open Randomized Control Single Centre Study. After obtaining patient's consent, 50 patients were selected following WHO selection criteria. The patients were grouped into two arms with one arm receiving Specific Tibetan Medicine for Hep' B and another arm receiving Traditional Tibetan Medicine for Hep' B. The primary objective was to evaluate the efficacy of Tibetan Medicine in treating Chronic Hep' B patients. The Specific Tibetan Medicine and the Traditional Tibetan Medicine were comparable for LFT and hepatitis B related symptoms. However in spite of randomization, the Specific Tibetan Medicine group i.e., group I have significantly higher LFT value and worse symptoms, indicating poorer LFT control in this study that received the Specific Tibetan Medicine. Both the group of Specific and Traditional Tibetan medicine showed significant improvement in Liver Function Test and HBV related symptoms. However, there is no any case of conversion from 49 patients who completed the six months course of study. The full report has been published in sMan-rTsis Journal of MTK, Vol, IV, Issue 1, August 2007.
Chronic Hepatitis B Study-II
Another comparative study on the evaluation of effectiveness and safety of Tibetan Medicine in treating chronic Hep'B was done at Bylakupee branch clinic of Men-Tsee-Khang for a period of six months in the year 2007. With one group receiving specific Tibetan Medicine and the other group receiving regular traditional Tibetan Medicine were compared for Hepatitis B viral load (HBV DNA), LFT, HBsAg and HBeAg during the course of the study. The data has been documented to be statistically analyzed by a statistician.